SPDR S&P BIOTECH ETF

XBI

$116.05

+45.52% (1 year change)

Avg closing price

Price range

Market Cap

$5.47 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

-

Total revenue in the last quarter.

Net Income

-

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

-

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.1066 (0.09%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

-

Earnings before interest expenses and taxes in the last quarter.

Employees

-

The number of full time employees.

Revenue & Earnings

Balance Sheet

SPDR S&P BIOTECH ETF

News

Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research

Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research

Biotechnology sector-related exchange traded funds were among the best performers Tuesday as the government program “Operation Warp Speed” allocates billions of dollars for a quick development and ...

ETF Trends ETF Trends, 4 months ago
Biotechnology Sector ETFs Are Leading the Charge

Biotechnology Sector ETFs Are Leading the Charge

Biotechnology sector-related exchange traded funds led the charge on Monday, with some breaking out to new highs. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution ...

ETF Trends ETF Trends, 6 months ago
How a Popular Biotech ETF Fits Into the Coronavirus Investing Landscape

How a Popular Biotech ETF Fits Into the Coronavirus Investing Landscape

The coronavirus outbreak is prompting investors to visit the healthcare sector, a trend that could benefit ETFs, including the SPDR S&P Biotech ETF (NYSEArca: XBI). XBI, one of the largest biotechn...

ETF Trends ETF Trends, 6 months ago